{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:20:37Z","timestamp":1767676837552,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009210","name":"Taiwan Food and Drug Administration","doi-asserted-by":"crossref","award":["DOH99-FDA-61404"],"award-info":[{"award-number":["DOH99-FDA-61404"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jfma.2016.10.015","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T15:46:57Z","timestamp":1482508017000},"page":"257-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: A cross-sectional study"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-2586","authenticated-orcid":false,"given":"Tso-Chou","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo-Ping","family":"Ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Joseph V.","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-O","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shung-Tai","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2016.10.015_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.jfma.2016.10.015_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12630-015-0520-y","article-title":"The prescription opioid epidemic: an overview for anesthesiologists","volume":"63","author":"Alam","year":"2016","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jfma.2016.10.015_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1212\/WNL.0000000000001766","article-title":"Opioids for chronic noncancer pain: to prescribe or not to prescribe\u2014what is the question?","volume":"85","author":"Nadeau","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2016.10.015_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2016.10.015_bib5","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2016.10.015_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/papr.12176","article-title":"Effectiveness of opioid analgesics in chronic noncancer pain","volume":"15","author":"Ferrari","year":"2015","journal-title":"Pain Pract"},{"key":"10.1016\/j.jfma.2016.10.015_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00540-010-1021-3","article-title":"Chronic opioid therapy in patients with chronic noncancer pain in Taiwan","volume":"24","author":"Lin","year":"2010","journal-title":"J Anesth"},{"key":"10.1016\/j.jfma.2016.10.015_bib8","first-page":"e97","article-title":"Chronic noncancer pain: characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic","volume":"57","author":"Mailis-Gagnon","year":"2011","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jfma.2016.10.015_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2010\/867201","article-title":"The long-term safety and efficacy of opioids: a survey of 84 selected patients with intractable chronic noncancer pain","volume":"15","author":"Watson","year":"2010","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jfma.2016.10.015_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5055\/jom.2013.0165","article-title":"The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer pain","volume":"9","author":"Ivanova","year":"2013","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jfma.2016.10.015_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1185\/03007995.2013.787978","article-title":"Survey of European patients assessing their own noncancer chronic pain: results from Spain","volume":"29","author":"Perez","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jfma.2016.10.015_bib12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.pain.2011.01.019","article-title":"Chronic pain in the Republic of Ireland\u2014community prevalence, psychosocial profile and predictors of pain-related disability: results from the Prevalence, Impact and Cost of Chronic Pain (PRIME) study, part 1","volume":"152","author":"Raftery","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jfma.2016.10.015_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jpainsymman.2012.02.014","article-title":"Trends in the consumption of opioid analgesics in Taiwan from 2002 to 2007: a population-based study","volume":"45","author":"Pan","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jfma.2016.10.015_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.aat.2016.05.002","article-title":"Key opioid prescription concerns in cancer patients: a nationwide study","volume":"54","author":"Lin","year":"2016","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"10.1016\/j.jfma.2016.10.015_bib15","unstructured":"Taiwan Food and Drug Administration. Physician guidelines on clinical Use of narcotics in chronic non-cancer pain. Revised 6 May 2015. Available from: http:\/\/www.fda.gov.tw\/TC\/law.aspx?pn=6&cid=183&cchk=9bb4ade3-dd48-4fbf-9bf2-b2c2ebd5d1b4. [Accessed October 30, 2016]. [in Chinese]."},{"key":"10.1016\/j.jfma.2016.10.015_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jfma.2015.08.001","article-title":"Long-term usage of narcotic analgesics by chronic intractable noncancer pain patients in Taiwan from 2003 to 2012","volume":"115","author":"Cheng","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2016.10.015_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J Pers Assess"},{"key":"10.1016\/j.jfma.2016.10.015_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0885-3924(99)00087-1","article-title":"Validation of the Brief Pain Inventory in a Taiwanese population","volume":"18","author":"Ger","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jfma.2016.10.015_bib19","first-page":"1257","article-title":"Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians: Part 1. General population","volume":"57","author":"Kahan","year":"2011","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jfma.2016.10.015_bib20","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2\u2014guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.jfma.2016.10.015_bib21","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1056\/NEJMp1507136","article-title":"Intensity of chronic pain\u2014the wrong metric?","volume":"373","author":"Ballantyne","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2016.10.015_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/pm\/pnw189","article-title":"Knowledge, attitude and practice survey of prescribing opioids for chronic noncancer pain in Taiwan \u2014 Comparison of pain and non-pain physicians","author":"Lin","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.jfma.2016.10.015_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpainsymman.2010.01.012","article-title":"An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study","volume":"40","author":"Edlund","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jfma.2016.10.015_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.6061\/clinics\/2012(07)08","article-title":"Trends and characteristics of pethidine use in Taiwan: a six-year-long survey","volume":"67","author":"Pan","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jfma.2016.10.015_bib25","unstructured":"Taiwan Food and Drug Administration. Guidelines on clinical use of pethidine. Available from: http:\/\/www.fda.gov.tw\/TC\/law.aspx?pn=6&cid=183&cchk=9bb4ade3-dd48-4fbf-9bf2-b2c2ebd5d1b4. [Accessed on Oct 30, 2016]. [in Chinese]."},{"key":"10.1016\/j.jfma.2016.10.015_bib26","first-page":"ES145","article-title":"Opioid-induced androgen deficiency (OPIAD)","volume":"15","author":"Smith","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.jfma.2016.10.015_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5055\/jom.2015.0270","article-title":"Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency","volume":"11","author":"Eichenbaum","year":"2015","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jfma.2016.10.015_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1155\/2011\/807123","article-title":"Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction","volume":"16","author":"Wong","year":"2011","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jfma.2016.10.015_bib29","first-page":"ES111","article-title":"Opioid-induced hypogonadism: why and how to treat it","volume":"15","author":"De Maddalena","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.jfma.2016.10.015_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1365-2265.2003.01772.x","article-title":"Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men","volume":"58","author":"Diver","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jfma.2016.10.015_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.j.pain.0000460308.86819.aa","article-title":"Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial","volume":"156","author":"Basaria","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jfma.2016.10.015_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpainsymman.2007.03.015","article-title":"Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety","volume":"35","author":"Noble","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jfma.2016.10.015_bib33","doi-asserted-by":"crossref","first-page":"141737","DOI":"10.1155\/2014\/141737","article-title":"Opioid-induced constipation: pathophysiology, clinical consequences, and management","volume":"2014","author":"Kumar","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jfma.2016.10.015_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/CEOR.S61602","article-title":"Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review","volume":"6","author":"Coyne","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.jfma.2016.10.015_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpain.2013.09.014","article-title":"The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving","volume":"15","author":"Martel","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.jfma.2016.10.015_bib36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4637.2007.00370.x","article-title":"What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review","volume":"9","author":"Fishbain","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.jfma.2016.10.015_bib37","first-page":"167","article-title":"Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in Kentucky","volume":"13","author":"Gilbert","year":"2010","journal-title":"Pain Physician"},{"key":"10.1016\/j.jfma.2016.10.015_bib38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/AJP.0b013e318174bb81","article-title":"Understand appropriate long-term use of opioids\u2014seventeen years and counting","volume":"24","author":"Clark","year":"2008","journal-title":"Clin J Pain"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664616303515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664616303515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T17:55:47Z","timestamp":1568656547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664616303515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0929664616303515"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2016.10.015","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2016.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}